- AU$17.56bn
- AU$17.43bn
- AU$2.24bn
- 93
- 10
- 59
- 56
Annual income statement for Cochlear, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,321 | 1,498 | 1,648 | 1,936 | 2,236 |
| Cost of Revenue | |||||
| Gross Profit | 984 | 1,099 | 1,250 | 1,453 | 1,696 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,583 | 1,124 | 1,248 | 1,547 | 1,761 |
| Operating Profit | -262 | 374 | 400 | 390 | 475 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -271 | 366 | 394 | 397 | 485 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -238 | 327 | 289 | 301 | 357 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -238 | 327 | 289 | 301 | 357 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -238 | 327 | 289 | 301 | 357 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.54 | 5.21 | 4.52 | 4.62 | 5.99 |
| Dividends per Share |